Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
915 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
Rank Status Study
1 Completed Pharmacogenomics and Effective Treatment With Clopidogrel
Condition: Pharmacogenomics and Cardiovascular Events
Intervention: Genetic: Pharmacogenomics
2 Completed Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy
Conditions: Stroke;   Transient Ischemic Attack;   Myocardial Infarction
Intervention: Other: Pharmacogenomics testing for clopidogrel responsiveness
3 Recruiting A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
Condition: Adverse Drug Reaction
Intervention: Device: Pharmacogenetic Intervention Arm (pharmacogenetic testing)
4 Recruiting Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis
Condition: Major Depressive Disorder
Intervention: Other: pharmacogenetic testing
5 Not yet recruiting Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting
Condition: Pharmacogenetics
Interventions: Other: Medication Therapy Management;   Other: Pharmacogenetic testing
6 Recruiting Pharmacogenetic Testing in an Outpatient Population of Patients With Depression
Condition: Depression
Intervention: Other: pharmacogenetic testing
7 Completed
Has Results
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
Conditions: Atrial Fibrillation;   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention: Genetic: Warfarin Dose based on pharmacogenetics
8 Completed The Implementation of Pharmacogenomics Into Primary Care in British Columbia
Condition: Pharmacogenetics
Intervention: Other: Decision support
9 Completed Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD
Conditions: Real Function Post Conversion From Prograf to Advagraf;   Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversion
Intervention:
10 Not yet recruiting Pharmacogenomics Registry to Assess Clinical Utility
Condition: Drug Side Effects
Intervention:
11 Recruiting LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology Outpatients
Condition: Malignant Tumor of Ill-defined Site
Intervention: Genetic: Pharmacogenomic Testing
12 Unknown  Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Disease
Interventions: Other: Genotype-guided warfarin dosing;   Other: Non-genotype guided warfarin dosing
13 Recruiting Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes
Condition: Major Depressive Disorder 1
Intervention: Genetic: Pharmacogenetic testing
14 Completed Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group
Conditions: Major Depressive Disorder;   Major Depression;   Unipolar Depression
Intervention: Drug: fluoxetine or desipramine
15 Unknown  Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients
Condition: Renal Transplantation
Interventions: Other: drug (tacrolimus and SchE) and genetics;   Drug: tacrolimus
16 Recruiting Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Condition: Genetics of Drug Metabolism
Intervention:
17 Recruiting ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
Condition: Acute Lymphoblastic Leukemia
Interventions: Genetic: Pharmacogenomics;   Other: Busulfan plasma level measurements
18 Completed Pharmacogenetic Testing Among Home Health Patients
Conditions: Adverse Drug Events;   Adverse Drug Reactions;   Drug Interaction Potentiation;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   Cytochrome P450 Enzyme Deficiency;   Cytochrome P450 CYP2D6 Enzyme Deficiency;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Cytochrome P450 CYP3A Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant;   Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Intervention: Genetic: Pharmacogenetic testing
19 Recruiting Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
20 Recruiting Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
Condition: Atrial Fibrillation
Interventions: Genetic: Pharmacogenetic anticoagulation;   Drug: Traditional anticoagulation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.